Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

28 Sep 2020

Why we need a “portfolio approach” to COVID-19 vaccine development
Hundreds of vaccine candidates against COVID-19 are under development. Predicting which of these will be successful is extremely difficult. That’s why we need multiple shots at goal, writes Nick Jackson, Head of Programmes and Innovative Technology at CEPI.

Read more

Read article

21 Sep 2020

Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX Facility
64 higher income economies have now joined the COVAX Facility, with a further 38 economies expected to sign in the coming days

Read more

18 Sep 2020

COVAX: A Moment of Truth in the Pandemic
To succeed, COVAX requires broad international buy-in, based on the recognition that no one is safe until everyone is.

Read more

04 Sep 2020

321 vaccine candidates against COVID-19 now in development
CEPI report analyses the global progress that has been made in the search for a COVID-19 vaccine

Read more

24 Aug 2020

172 countries & multiple candidate vaccines engaged in COVID-19 Vaccine Global Access Facility
172 economies are now engaged in discussions to potentially participate in COVAX, with the goal of bringing the pandemic under control via equitable access to COVID-19 vaccines.

Read more

21 Aug 2020

How to measure the success of a COVID-19 vaccine?
Dr Melanie Saville, CEPI’s Director of Vaccine Development, discusses what a successful vaccine against COVID-19 would involve, some of the unknowns and the challenges that vaccine developers are wrestling with, and what makes CEPI’s approach distinctive

Read more

17 Aug 2020

COVAX seeks civil society representatives to contribute to ensuring equitable global access to COVID-19 vaccines

Read more

13 Aug 2020

CEPI reserves manufacturing capacity for COVID-19 vaccines at SK bioscience
CEPI has reserved vaccine manufacturing capacity at SK bioscience in 2020 and 2021 which will support the COVAX goal to produce 2 billion doses of safe and effective vaccine by the end of 2021.

Read more

Read article

05 Aug 2020

CEPI survey assesses potential COVID-19 vaccine manufacturing capacity
Results show enough manufacturing capacity is available to meet potential demand through end of year 2021 for COVID-19 vaccines

Read more

21 Jul 2020

CEPI extends funding call to accelerate development and global manufacture of COVID-19 vaccines
The extended Call for Proposals, supported by the European Commission, invites applications from vaccine developers to accelerate vaccine development and ensure that manufacturing capacity will meet global demand as quickly as possible.

Read more

15 Jul 2020

More than 150 countries engaged in COVID-19 Vaccine Global Access Facility
Interest from governments represents more than 60% of the world’s population.

Read more

©2020 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.